Bone-specific response according to MDA criteria predicts immunotherapy efficacy among advanced non-small cell lung cancer (NSCLC) patients

PURPOSE: The presence of bone metastasis at baseline has been associated with dismal prognosis under immunotherapy in advanced non-small cell lung cancer (NSCLC). Response Evaluation Criteria in Solid Tumors (RECIST) criteria may be limited for bone-specific response evaluation. Whether their assess...

Descripción completa

Detalles Bibliográficos
Autores principales: De Giglio, Andrea, Deiana, Chiara, Di Federico, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article – Clinical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10097761/
https://www.ncbi.nlm.nih.gov/pubmed/35750899
http://dx.doi.org/10.1007/s00432-022-04120-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10097761/
https://www.ncbi.nlm.nih.gov/pubmed/35750899
http://dx.doi.org/10.1007/s00432-022-04120-z

Ejemplares similares